GABA_B R1 Antibodies

Santa Cruz Biotechnology delivers a wide array of GABA_B R1 monoclonal antibodies for research focused on understanding the GABA_B receptor system. GABA_B R1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GABA_B R1 plays a crucial role in mediating inhibitory neurotransmission in the central nervous system, contributing to the regulation of neuronal excitability and synaptic plasticity. The significance of GABA_B R1 is highlighted by its involvement in various neurological processes and disorders, making it a key target for research in neuropharmacology and neurobiology. Understanding GABA_B R1 function and regulation is essential for developing therapeutic strategies for conditions such as epilepsy, anxiety, and schizophrenia. Researchers can utilize GABA_B R1 monoclonal antibodies to explore GABAergic signaling mechanisms and their impact on neural function. GABA_B R1 monoclonal antibodies enable detailed investigation of receptor distribution, expression patterns, and molecular interactions. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing neuroscience research and developing potential therapeutic interventions.